Oncology

Latest News

PD-1 blockade has previously shown success in a first-line setting in ES-SCLC, and nab-paclitaxel is albumin-bound and solvent-free, which the investigators explained may minimize the toxicity associated with paclitaxel therapy. | Image credit: didesign - stock.adobe.com
Camrelizumab Plus Carboplatin, Nab-Paclitaxel Shows Efficacy in ES-SCLC

August 29th 2025

The 6-month progression-free survival rate for the combination therapy was 52.2%.

For rent sign | Image Credit: David Gales - stock.adobe.com
Housing Assistance May Help Renters With Cancer Better Withstand Medical Financial Strain

August 28th 2025

Patient with cancer undergoing chemotherapy | Image credit: RFBSIP – stock.adobe.com
Many Patients With Advanced Cancer Report Care Misaligned With Their Goals

August 25th 2025

Innovation vs Affordability: Cancer Care’s Cost Crisis and Access Gap
Innovation vs Affordability: Cancer Care’s Cost Crisis and Access Gap

August 21st 2025

The investigators found that tumor mutational burden and PD-L1 expression, which have traditionally been used as indicators of immunotherapy efficacy, had little predictive value for survival in this cohort. | Image credit: Dragana Gordic - stock.adobe.com
Predictive Model Forecasts Advanced NSCLC Outcomes

August 14th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations
Continuing Medical Education
View All
August 30th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
August 30th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

Site Logo
August 31st 2015

Gene Signature Could Predict Development of Pancreatic Cancer, Allow Personalized Treatment

Surabhi Dangi-Garimella, PhD
A novel microRNA gene signature could guide earlier intervention in pancreatic cancer.
Site Logo
August 31st 2015

ASCO Updates Guidelines for Advanced Lung Cancer

Surabhi Dangi-Garimella, PhD
An expert panel of ASCO developed recommendations for advanced lung cancer treatment after reviewing published literature.
Site Logo
August 31st 2015

New 340B Draft Guidance May Increase Bureaucracy

Surabhi Dangi-Garimella, PhD
The new guidance released by HRSA proposes to improve oversight over the drug pricing program.
Site Logo
August 30th 2015

Pharmacy Cost Trends Expected to Continue in the Double Digits

AJMC Staff
Pharmacy cost trends are expected to increase 10% up from 6.3% the year before, with specialty pharmacy trends experiencing the largest increases, according to a survey from Aon Health.
Site Logo
August 28th 2015

Protein Biomarker Can Predict Response to FOLFIRINOX in Pancreatic Cancer

Surabhi Dangi-Garimella, PhD
The study published in JNCI has identified CES2 expression as a predictor of response to FOLFIRINOX.
Jennifer Malin, MD, Explains Payer Role In Changing Cancer Care
August 28th 2015

Jennifer Malin, MD, Explains Payer Role In Changing Cancer Care

While the shift to cancer becoming more of a chronic disease does not have a huge change on the approach of the payer, there are some new challenges to address, said Jennifer Malin, MD, medical director for oncology at Anthem.
Site Logo
August 27th 2015

Childhood Cancer Increases Risk of Recurrent Stroke

Surabhi Dangi-Garimella, PhD
Published in the journal Neurology, the study identified childhood cancer, along with hypertension and age, as a risk factor for recurrent stroke.
Site Logo
August 27th 2015

A New Decision Support Tool for Surgical Oncology Launched

AJMC Staff
A pathways company has followed up its medical and radiation oncology clinical decision tools with a new surgical oncology platform.
Site Logo
August 26th 2015

As Date for First Biosimilar to Hit the Market Draws Close, Reimbursement Remains Fuzzy

Surabhi Dangi-Garimella, PhD
The Biosimilars Council wants CMS to hold back on Medicare Part B reimbursement for biosimilars.
Site Logo
August 26th 2015

Do Survivorship Care Plans Improve PROs Among Cancer Patients?

Surabhi Dangi-Garimella, PhD
An article published in the Journal of Clinical Oncology finds that survivorship care plans may not greatly improve patient satisfaction with their care.
Site Logo
August 25th 2015

Colorectal Cancer Screening Gets Special Look in AJMC Papers

The deadly nature of colorectal cancer merited attention in the Affordable Care Act, which called for eliminating cost-sharing for screening to prevent deaths. The future of colorectal screening, its cost-effectiveness, and a possible way to limit unneeded tests are the topic of a recent series of papers in The American Journal of Managed Care.
Site Logo
August 25th 2015

Study Shows Promise for EHR-Based Algorithm in Reducing Cancer Diagnostic Delays

Surabhi Dangi-Garimella, PhD
A trigger built in patient EHRs can avoid follow-up delays in those at risk for developing certain types of cancers, a JCO study shows.
Site Logo
August 25th 2015

A Payer-Provider Collaboration to Add Value to Oncology Care

Surabhi Dangi-Garimella, PhD
Aetna and the University of Chicago Medicine kicked off a value-based oncology medical home model in July this year in an effort to transition from fee-for-service to value-based care.
Site Logo
August 24th 2015

Another Cancer Drug Pricing Tool, This Time From NCCN

Surabhi Dangi-Garimella, PhD
The National Comprehensive Cancer Network has announced the development of another "price" calculator that will help stakeholders assess the relative "value" of available options.
Site Logo
August 21st 2015

New Study Unravels Link Between Obesity and Breast Cancer

Surabhi Dangi-Garimella, PhD
The study published in Science Translational Medicine found that tissue stiffening in the breasts of obese women can drive the development of malignant disease.
Dr Veena Shankaran Encourages Patient-Physician Communication of Care Costs
August 20th 2015

Dr Veena Shankaran Encourages Patient-Physician Communication of Care Costs

There are many cost-related pieces in the grand picture of care that are devastating to families and patients, including copayments, hospital visit bills, transportation fees, and drug prices.
Site Logo
August 20th 2015

Phase 2 Basket Trial Results Claim Success in BRaf V600-Mutated Cancers

Surabhi Dangi-Garimella, PhD
Conducted by researchers at the Memorial Sloan Kettering Cancer Center, phase 2 results from a basket trial evaluated the efficacy of vemurafenib on nonmelanoma BRaf V600-mutated cancers in 122 patients across 23 global centers.
Site Logo
August 18th 2015

Pilot of Decision Support to Individualize Colorectal Cancer Screening Recommendations

Amy R. Schwartz, MD Forrest L. Levin, MS Joseph A. O'Neil, Jr, BS R. Scott Braithwaite, MD, MSc
Colorectal cancer screening involves balancing immediate harms with longer-term benefits; electronic medical record decision support may facilitate personalized benefit/harm assessment.
Site Logo
August 16th 2015

The Evolving Treatment Landscape and Innovative Payment Models in Oncology: An Expert Summit

This supplement summarizes proceedings from the AJMC Oncology Stakeholders Summit, Spring 2015 series, at which experts gathered to discuss the evolving treatment landscape in oncology and the development of innovative payment models to help reduce the cost of care without sacrificing quality of care.
Site Logo
August 16th 2015

Special Issue Looks at What's Ahead in Precision Medicine

New resources are being directed toward precision medicine, particularly in cancer care. With that in mind, Evidence-Based Oncology, a publication of The American Journal of Managed Care, devotes its current issue to articles and commentaries on this growing field.
Site Logo
August 14th 2015

Chemoprevention With Oral Contraceptives Could Be a Reality

Surabhi Dangi-Garimella, PhD
Evidence provided by a study published in The Lancet Oncology affirms that oral contraceptives provide long-term protection against endometrial cancer.
Site Logo
August 14th 2015

Gefitinib Approved as Frontline in EGFR-Positive NSCLC

Surabhi Dangi-Garimella, PhD
Site Logo
August 14th 2015

Need for Palliative Care for Improved Performance at the End of Life

Surabhi Dangi-Garimella, PhD
An article published in JAMA Oncology underscores the need for efforts to improve quality of life for cancer patients.
Site Logo
August 14th 2015

CHAARTED Study: Conceptual Shift in Early Prostate Cancer Treatment

Surabhi Dangi-Garimella, PhD
Analysis of results from the CHAARTED trial, published in the New England Journal of Medicine, has found that 6 cycles of chemotherapy (docetaxel) before androgen-deprivation therapy early in the treatment of metastatic prostate cancer significantly improved overall survival than treatment with ADT alone.
Site Logo
August 14th 2015

Sonidegib Approved for Basal Cell Carcinoma

Surabhi Dangi-Garimella, PhD
Site Logo
August 14th 2015

JAMA Oncology Study Validates Patient-Reported Outcomes

Surabhi Dangi-Garimella, PhD
A multicollaborative study conducted for the National Cancer Institute has resulted in a tool called the Common Terminology Criteria for Adverse Events (PRO-CTCAE). PRO-CTCAE can help integrate the patient perspective into adverse event reporting.
Site Logo
August 13th 2015

The Diagnosis for Diagnostics: Changes to Medicare Payment and Coverage of Clinical Laboratory Tests

Adam Borden, MHA Danielle Showalter, MPH Geoffrey Storchan, PhD Kathleen Hughes, MBA
The basis for determining Medicare payment rates for clinical diagnostic laboratory tests is changing. These changes will be important for all payers and providers to follow for future reimbursement and contract negotiations.
Site Logo
August 13th 2015

No Solution in Sight Yet With the Federal 340B Program, Say Stakeholders

Surabhi Dangi-Garimella, PhD
A panel of healthcare experts invited by The American Journal of Managed Care participated in the Oncology Stakeholders Summit, Spring 2015 Peer Exchange, to discuss 340B and other issues in oncology care.
Site Logo
August 13th 2015

Choosing Well in Older Breast Cancer Patients: Retrospective Study Provides Leads

Surabhi Dangi-Garimella, PhD
A study published in the Journal of the American Geriatrics Society found that older women with breast cancer have a poor response to chemotherapy, while older patients with advanced colon cancer (both men and women) did well.
Site Logo
August 12th 2015

The Need to Eliminate Barriers to Personalized Medicine

Alan Balch, PhD
Precision medicine will perhaps establish some of the most important biomedical innovations of our generation. However, for that future to become a reality, we have to create an access and reimbursement environment that is conducive to precision care.
<1
...
125126127128129130131132133
...
188>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo